A surge of 147% in a single session is an unusual occurrence in biotech — and nearly unprecedented for a company that has spent years trading discreetly under the radar. However, that is precisely ...
Live Executive Presentations From Public Life Sciences Companies Across a Broad Range of Therapeutic and Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results